Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Shanghai Jia Fu Medical Apparatus
Shanghai, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Shanghai Jia Fu Medical Apparatus partnered with Medistem to develop endometrial regenerative cell (ERC) universal donor stem cell products for the Chinese market, with initial focus on treating critical limb ischemia, an advanced form of peripheral artery disease.[6]
- Therapeutic areas
- Cardiovascular
- Modalities
- Stem cell therapy
- Industry
- Biotech
02
Partnerships
Medistem
Beyond the preview
Go deeper on Shanghai Jia Fu Medical Apparatus.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Shanghai Jia Fu Medical Apparatus.